1965 -1970s: The Beginning
|
1965
|
|
Incorporation as American Medical Research, Inc. |
1968
|
|
 Initial Public Offering and Name change to DIAGNOSTIC, INC. |
1970s
|
|
Primary business is manufacturing Microbial Diagnostic Devices. |
| |
|
|
1980s: Development of Fermentation-Based Hyaluronic Acid
|
1981
|
|
Research program initiated to develop fermentation-based hyaluronan manufacturing technology.
|
1983
|
|
First commercial hyaluronate contract with Alcon Laboratories, Inc. (originally Cilco, Inc.)
|
| |
|
Three-for-one stock split.
|
1984
|
|
Restructuring: Sale of Microbial Disgnostics business; expansion of biotechnology manufacturing activity. |
1987
|
|
 Name changed to Lifecore Biomedical, Inc.
Acquisition of Hydroxylapatite technology (OrthoMatrix, Inc. of Dublin, California).
|
1989
|
|
Supply Agreement with ETHICON, INC., a Johnson & Johnson company, development of GYNECARE INTERGEL Adhesion Prevention Solution. |
| |
|
|
1990s: Integration of the Dental Division
|
1990
|
|
Introduction of the Sustain® Dental Implant System with direct sales and marketing activities. |
1991
|
|
 Opening of Chaska Headquarters facility. |
1992
|
|
 OrthoMatrix Division is renamed Lifecore Oral Restorative Division.
|
| |
|
Acquisition of Sustain® Dental Implant System. |
| |
|
Introduction of HAPSET® Hydroxylapatite Bone Graft Plaster.
|
1993
|
|
Chaska facility aseptic fill suite operational.
|
| |
|
Ophthalmic research agreement with Bausch & Lomb.
|
1994
|
|
Acquisition of Implant Support Systems, Inc. dental implant business.
|
| |
|
Chaska hyaluronate manufacturing facility validation.
|
| |
|
Minneapolis manufacturing capacity consolidated in Chaska.
|
| |
|
Bausch & Lomb ophthalmic hyaluronate product development agreement.
|
|
|
|
ETHICON, INC., exclusive supply, marketing, and technology transfer agreements; transfer of INTERGEL Solution product development project to Lifecore. |
|
|
|
Johnson & Johnson Medical, Inc., exclusive research and supply agreement for wound care management product. |
1995
|
|
Bausch & Lomb supply agreement signed for Amvisc® and Amvisc® Plus Ophthalmic Hyaluronate Solutions.
|
| |
|
Orphan Medical, Inc. supply agreement for Caprogel® Topical Aminocaproic acid.
|
|
|
|
ISO 9001 and CE Mark certifications. |
|
|
|
INTERGEL Solution IDE for adhesion prevention clinical study. |
|
|
|
Formation of the Lifecore Italian subsidiary, Lifecore S.p.A. in Verona, Italy. |
1996
|
|
Mentor Opthalmics hyaluronate private label supply agreement. |
|
|
|
INTERGEL Solution pilot clinical study completed; pivotal clinical study commenced in U.S. and Europe.
|
| |
|
INTERGEL Solution patents allowed.
|
|
|
|
Introduction of CAPSET® Bone Graft Barrier. |
1997
|
|
Oral Restorative distribution begins in Japan.
|
| |
|
Distribution agreement of LifeCell’s AlloDerm® Acellular Dermal graft.
|
|
|
|
 Acquisition of TefGen-FD™ Membrane product line. |
|
|
|
Website launched: www.lifecore.com. |
|
|
|
Chaska facility expansion. |
|
|
|
Completion of INTERGEL Solution Pivotal Trial Data Analysis indicating safety and efficacy. |
1998
|
|
Rollout of INTERGEL Solution in Europe by Johnson & Johnson. |
|
|
|
Minnesota Technology Fast 50 Winner. |
1999
|
|
INTERGEL Solution pre-market approval application (PMA) is filed with the US FDA. |
| |
|
Minnesota Technology Fast 50 Winner. |
| |
|
|
2000 & beyond: Continuing Purposeful Innovation into the Millennium
|
2000
|
|
 STAGE-1® Single Stage Dental Implant introduced in U.S. |
|
|
|
Musculoskeletal Transplant Foundation (MTF) agreement signed for orthopedic hyaluronan supply. |
|
|
|
Lifecore Biomedical GmbH begins operations in Bonn, Germany. |
| |
|
INTERGEL Solution PMA Supplement filed with the US FDA. |
|
|
|
Lifecore Biomedical AB subsidiary established in Stockholm. |
|
|
|
and INTERGEL Solution PMA rejected by FDA. |
2002
|
|
FDA decision on INTERGEL Solution reversed by unanimous decision of historic first FDA Medical Devices Dispute Resolution Panel. |
|
|
|
Johnson & Johnson’s GYNECARE, INC., the Women’s Healthcare Division of ETHICON, INC., begins US marketing of INTERGEL Solution in 3Q. |
|
|
|
STAGE-1 Single Stage Dental Implant System approved in Korea and Japan. |
|
|
|
Launch of Global e-commerce website for Oral Restorative Division. |
2003
|
|
INTERGEL Solution voluntarily withdrawn from the market in 3Q. |
2004
|
|
HEXAL AG supply agreement signed for hyaluronan knee therapeutic product. |
|
|
|
Lifecore Biomedical names Dennis Allingham as President & CEO. |
|
|
|
Lifecore Biomedical names new officers. David Noel as VP of Finance & CFO and Larry Hiebert as VP of Operations. |
|
|
|
 RENOVA® Internal Hex Dental Implant System introduced. |
2005
|
|
Advanced Medical Optics (AMO) signs agreement for distribution of private label hyaluronan viscoelastic product. |
|
|
|
Lifecore secures worldwide marketing rights to hyaluronan anti-adhesion product. |
|
|
|
 Lifecore introduces CALMATRIX®, a calcium sulfate bone graft binder, and CalForma®, a calcium sulfate bone braft barrier, to existing regeneration product offering.
|
|
|
|
Lifecore Biomedical names Kipling Thacker , PhD as VP of New Business Development and names Luther Griffith to its Board of Directors. |
|
|
|
Lifecore renews Supply Agreement with Alcon, Inc. |
|
|
|
Minnesota Department of Labor & Industry awards Lifecore with MNSHARP Certification. |
2006
|
|
 Lifecore celebrates 40th Anniversary. |
|
|
|
Lifecore Biomedical SAS subsidiary established in Beauzelle, France. |
|
|
|
 Lifecore Prima™ Implant System introduced. |
| |
|
Minnesota Department of Labor & Industry re-certifies Lifecore with MNSHARP Certification. |
|
|
|
Martin J Emerson joins Board of Directors. |
|
|
|
Lifecore promotes Larry Hiebert to Vice President & General Manager of the Hyaluronan Division and appoints Jim Hall to Vice President of Technical Operations. |
2007
|
|
 Lifecore's Oral Restorative Division becomes Lifecore Dental. |
| |
|
NASDAQ names Lifecore to its NASDAQ Global Select Market. |
|
|
|
Lifecore Biomedical announces license agreement with Cleveland Clinic. |
2008
|
|
Lifecore ranked 43 in Fortune Small Business 2007 FSB 100-America’s Fastest-Growing Small Companies. |
|
|
|
Lifecore ranked 52 in Business 2.0 2007 list of 100 Fastest-Growing Tech Companies. |
| |
|
Dennis Allingham named 2007 BioScience Success Stories award recipient by Twin Cities Business magazine. |
| |
|
Lifecore agrees to be acquired by Warburg Pincus for $17.00 per share in cash. |
| |
|
Lifecore renews Manufacturing Agreement with Alcon, Inc.
|